 |
 |
 |
||||||||||||||||||
|
 PARTNERING In addition to development programs targeting oncology treatments already on the market, DNAR is working on biomarker panels for drugs in development, and welcomes inquiries from companies who have new therapies for which DNAR’s biomarkers might be relevant. |
|
||||||||||||||||||
 |
 |
 |
